Epidemiology and Outcomes of Neurofibromatosis Type 1 (NF-1): Multicenter Tertiary Experience
Mohammed Almuqbil,Fatimah Yaseen Alshaikh,Waleed Altwaijri,Duaa Baarmah,Raid Harb Hommady,Maryam Yaseen Alshaikh,Fares Alammari,Meshal Alhussain,Reem Almotawa,Faris Alqarny,Amna Kashgari,Rayan Alkhodair,Jumanah N Alkhater,Lujeen Nasser Alkhater,Sawsan A Alharthi,Mada Abdulkarim Alsadi,Ahmed AlRumayyan
DOI: https://doi.org/10.2147/jmdh.s454921
2024-03-23
Journal of Multidisciplinary Healthcare
Abstract:Mohammed Almuqbil, 1– 3 Fatimah Yaseen Alshaikh, 4 Waleed Altwaijri, 1– 3 Duaa Baarmah, 5 Raid Harb Hommady, 2, 3 Maryam Yaseen Alshaikh, 1 Fares Alammari, 6 Meshal Alhussain, 7 Reem Almotawa, 8 Faris Alqarni, 9 Amna Kashgari, 1, 10 Rayan Alkhodair, 1, 2, 11 Jumanah N Alkhater, 1 Lujeen Nasser Alkhater, 6 Sawsan A Alharthi, 11 Mada Abdulkarim Alsadi, 12 Ahmed AlRumayyan 1– 3 1 College of Medicine, King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh, Saudi Arabia; 2 King Abdullah International Medical Research Center (KAIMRC), Ministry of National Guard, Riyadh, Saudi Arabia; 3 Division of Pediatric Neurology, Department of Pediatrics, King Abdullah Specialist Children's Hospital (KASCH), National Guard Health Affairs (NGHA), Riyadh, Saudi Arabia; 4 Collage of Medicine, Princess Nora University, Riyadh, Saudi Arabia; 5 Department of Pediatrics, King Abdullah Bin Abdulaziz University Hospital, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia; 6 College of Medicine, Almaarefa University, Riyadh, Saudi Arabia; 7 College of Medicine, King Khalid University, Abha, Saudi Arabia; 8 Royal College of Surgeons, Dublin, Ireland; 9 College of Dentistry, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; 10 Department of Radiology, King Abdullah Specialist Children's Hospital (KASCH), National Guard Health Affairs (NGHA), Riyadh, Saudi Arabia; 11 Division of Dermatology, King Abdulaziz Medical City, Riyadh, Saudi Arabia; 12 Division of Otolaryngology, Head and Neck Surgery, King Abdulaziz University Hospital, Riyadh, Saudi Arabia Correspondence: Mohammed Almuqbil, College of medicine, King Saud bin Abdulaziz University for health Sciences (KSAU-HS), Prince Mutib Ibn Abdullah Ibn Abdulaziz, Ar Rimayah, P.O. Box 22490, MC 1940, Riyadh, 11426, Saudi Arabia, Tel +966-11-8011111 ext 53594, Email ; Purpose: The aim of this manuscript was to assess the epidemiology and clinical features of Neurofibromatosis type 1 (NF-1) based on the newly published revised NF-1 diagnostic criteria and to evaluate complications of NF-1 including neurodevelopmental disorders. Patients and methods: A retrospective cross-sectional observational study was conducted in the Ministry of National Guard Health Affairs (MNGHA) healthcare organization branches including four tertiary hospitals and 51 primary health care centers in different regions in Saudi Arabia. This study included all patients diagnosed with NF1 using the revised NIH diagnostic criteria published in 2021 that were registered at the electronic medical records (EMR) from 2015 to 2021. Results: A total of 184 patients fulfilled the diagnostic criteria and were included in this study. The median age at diagnosis was 11 years (IQR: 4.00– 20.25). The most encountered diagnostic criteria in this study were Café-au-lait macules (85.3%), and (42.9%) were found to have two or more neurofibromas with plexiform neurofibroma being the most common subtype (23.36%), approximately (36.4%) of the patient with optic pathway glioma. Nearby (26.6%) of the patients displayed different type of tumors. Iris Lisch nodules were presented in 36.4% of patients at a median age of 12 years (IQR: 9.0– 21.8). Cardiovascular abnormality was encountered in 9.8% of the patients. Around 27.7% of the patients reported headache and 11.4% of the patient suffered from different type of epilepsy. Besides, 10.5% of the patients had intellectual disability, 33.8% suffered from communication disorders, and 4.9% patients had ADHD. Conclusion: The results of this study will enable practitioners to adopt a more holistic approach and prioritize numerous attributes, which they can subsequently incorporate into their therapeutic methodologies. Furthermore, the identification of these attributes will facilitate an expeditious and accurate diagnosis. Hence, the implementation of intervention during its nascent phase may result in a more advantageous consequence. Keywords: neurofibromatosis type 1, café-au-lait macule, glioma, neurofibromas Neurofibromatosis type 1 (NF-1), also known as von Recklinghausen's disease, is a hereditary condition that impacts various bodily systems and presents with a notable tendency to develop tumors, along with associated neurological and cutaneous symptoms. 1 This condition has an incidence of 1 in 2000 to 3000 individuals in the general population, regardless of gender or ethnicity, and is typically inherited in an aut -Abstract Truncated-
health care sciences & services